NLRP3 Inhibitors

Topical acne treatment can be effective in treating acne, as well as acne outbreaks brought on by stress. The dose can be different depending on what imperturbably tadalafil your doctor prescribed for you. If you have the flu: your doctor will prescribe antibiotics.

You may experience severe pain or pressure in the eye or even loss of vision in the eye. It is the most effective method of treatment for these type of conditions. The following are some of the best anti-bacterial wipes you can buy:

More info about license types

Free of 19 % VAT (except in Germany and also in the European Union without valid intl. VAT no), delivery costs do not apply.

You can also order this product via email or fax, please download the Order Form

Publisher: La Merie Publishing
Format: Word Table
Product Line: Target Pipeline List
Product Code: LMTPL044
Release Date: April of 2019
Category: Tag:

NLRP3 Inhibitors – Target Pipeline List 04/2019

Targets: NLRP3; Nucleotide-binding oligo-merization (NOD)-like Receptor Family Pyrin Domain Containing Protein 3

This Target Pipeline List provides an overview of small molecule inhibitors of NLRP3 in development for treatment of chronic inflammatory diseases.

A spectrum of inflammatory diseases are associated with mutations in the NLR gene family. The NLR family is composed of 23 cytosolic proteins with variable recognition motifs that are responsible for detecting cellular threats using pathogen-associated molecular patterns (PAMP) or damage-associated molecular patterns (DAMP). After recognition, some NLRs change shapes to assemble a multi-protein structure known as an inflammasome, which activates inflammatory processes.

By blocking inflammasome activity, small-molecule inhibitors may help reduce overactive cytokine production and stop inflammatory signaling.

Nembers of the NLR family include NLRP1, NLRP3, NLRP6, NLRP10 and NLRC4. By targeting components of the inflammasome, the potential exists for NLR inhibitors to be used for multiple indications and to serve as innate immune modulators for the treatment of liver fibrosis/non-alcoholic steatohepatitis (NASH), neurodegeneration/Alzheimer’s or Parkinson’s disease, cardio-metabolic diseases such as atherosclerosis and type 2 diabetes, gout, age-related macular degeneration and autoimmune diseases that include systemic sclerosis, inflammatory bowel disease (IBD), vitiligo, type 1 diabetes, celiac disease, systemic lupus erythematosus and rheumatoid arthritis.

La Merie Publishing offers a low-cost product service providing information about active R&D projects for a given target in the format of Word tables.

The Word document with the Table is delivered by e-mail within 24 hours after receipt of the confirmed order. Usually, delivery time is less than one hour if ordered during European business hours.

Download information leaflet about deliverable and methodology of Target Pipeline Lists.

Single User License:

This license allows for use of a report by one named person, explicitly confirmed at point of sale

Departmental License:

This license allows for use of a report by members of the same Dept within the same enterprise location or of the same international Project Group.

Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise location.

Global Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise worldwide.


Custom Support & Sale:

Mon–Fri: 10:00 am –5:00 pm GMT+01